VERTEX PHARMACEUTICALS INC / MA reports

Company location: Boston, MA
Fiscal year end: 31 December

VERTEX PHARMACEUTICALS INC / MA has filed 3,632 SEC EDGAR filings since 15 Feb 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page

25

Current page

34

4

FORM 4 SUBMISSION

Filing date: 03 Feb 2022
Reporting date: 01 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Feb 2022
Reporting date: 01 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-42126

SC 13G/A filing

Filing date: 01 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Feb 2022
Reporting date: 28 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-19319

8-K

Filing date: 26 Jan 2022
Reporting date: 26 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Jan 2022
Reporting date: 14 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Jan 2022
Reporting date: 14 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Nov 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Nov 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Nov 2021
Reporting date: 15 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-19319

10-Q

Filing date: 03 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-19319

8-K

Filing date: 02 Nov 2021
Reporting date: 02 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 18 Oct 2021
Reporting date: 15 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 18 Oct 2021
Reporting date: 15 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Aug 2021
Reporting date: 19 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Aug 2021
Reporting date: 02 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Aug 2021
Reporting date: 30 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-19319

10-Q

Filing date: 30 Jul 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-19319

8-K

Filing date: 29 Jul 2021
Reporting date: 29 Jul 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jul 2021
Reporting date: 15 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jul 2021
Reporting date: 15 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-19319

8-K

Filing date: 24 Jun 2021
Reporting date: 23 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 04 Jun 2021
Reporting date: 02 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 03 Jun 2021
Reporting date: 01 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .